Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-29 18:18:21 - browse：8

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： FDA approves potent Eli Lilly obesity drug, Zepbound

WSS

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Virtual care provider acquires bankrupt Pear's prescription apps

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

What STAT readers think about the FDA and patient advocacy

Medicare Advantage beneficiaries sue Humana over algorithm use

David Ricks of Eli Lilly: best biopharma CEO of 2023

entertainment

Wikipedia

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Albert Bourla of Pfizer: worst biopharma CEO of 2023

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Diversify hospital leadership teams to protect BIPOC patient health

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biotech incubator Curie.Bio graduates its first startup

Moonlake's readout produced a cash windfall. Risks remain

STAT Executive Editor Rick Berke on STAT's 8th birthday

Psychedelics group wrestles with new pharma identity

Editas, Vertex strike deal on CRISPR

leisure time

Victims of gun violence feel impacts long after bullet wound

Extreme heat events are a public health emergency

SEC charges former device maker CEO with $41 million fraud

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

CRISPR gene editing developments we’re watching in 2024

hotspot

Wikipedia

knowledge

focus